aXichem AB

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: SE0005250719
SEK
1.36
-1.14 (-45.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

The company has declared Positive results for the last 3 consecutive quarters

  • NET SALES(HY) At SEK 4.78 MM has Grown at 341.18%
  • OPERATING CASH FLOW(Y) Highest at SEK -11.3 MM
  • NET PROFIT(HY) Higher at SEK -11.19 MM
2

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

SEK 115 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-30.45%

stock-summary
Price to Book

1.98

Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.75%
0%
13.75%
6 Months
11.89%
0%
11.89%
1 Year
3.8%
0%
3.8%
2 Years
-82.76%
0%
-82.76%
3 Years
-90.54%
0%
-90.54%
4 Years
-95.22%
0%
-95.22%
5 Years
-97.78%
0%
-97.78%

aXichem AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
59.07%
EBIT Growth (5y)
-6.12%
EBIT to Interest (avg)
-10.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.12
Tax Ratio
0.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.90
EV to EBIT
-8.96
EV to EBITDA
-11.75
EV to Capital Employed
3.02
EV to Sales
14.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.68%
ROE (Latest)
-33.61%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 94.12% vs 142.86% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 42.37% vs -11.32% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.60",
          "val2": "3.40",
          "chgp": "94.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-4.20",
          "chgp": "45.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.40",
          "val2": "-5.90",
          "chgp": "42.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-530.40%",
          "val2": "-1,586.70%",
          "chgp": "105.63%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 377.78% vs -64.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.42% vs -20.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "1.80",
          "chgp": "377.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-13.00",
          "val2": "-15.70",
          "chgp": "17.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "3.50",
          "chgp": "-42.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.80",
          "val2": "-20.80",
          "chgp": "14.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,790.20%",
          "val2": "-9,928.10%",
          "chgp": "813.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary

Jun'25
Mar'25
Change(%)
Net Sales
6.60
3.40
94.12%
Operating Profit (PBDIT) excl Other Income
-2.30
-4.20
45.24%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.40
-5.90
42.37%
Operating Profit Margin (Excl OI)
-530.40%
-1,586.70%
105.63%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 94.12% vs 142.86% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 42.37% vs -11.32% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
8.60
1.80
377.78%
Operating Profit (PBDIT) excl Other Income
-13.00
-15.70
17.20%
Interest
2.00
3.50
-42.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-17.80
-20.80
14.42%
Operating Profit Margin (Excl OI)
-1,790.20%
-9,928.10%
813.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 377.78% vs -64.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 14.42% vs -20.23% in Dec 2023

stock-summaryCompany CV
About aXichem AB stock-summary
stock-summary
aXichem AB
Specialty Chemicals
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Company’s products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Company’s shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.
Company Coordinates stock-summary
Company Details
Sodergatan 26 , MALMO None : 211 34
stock-summary
Tel: 46 46 7800673
stock-summary
Registrar Details